Image 01
Zelapar Tablet, Orally Disintegrating
Product Images NDC 0187-0453
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zelapar (NDC 0187-0453). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bausch Health Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image 02
Image 03
This is a product description of Zelapar’ Orally Disintegrating Tablets made by Bausch Health. The tablets contain 155mg of Selegine HCL and come in six sachet pouches with ten tablets in each pouch. The outer pouch is child-resistant while the blister packs and sachet pouches are not. The product is not to be pushed through oil, and it must be kept out of reach of children at all times. The tablets must be stored in the sachet pouch, which should be kept sealed or closed inside the clear child-resistant pouch provided. The product should be used within three months of opening the sachet pouch, and the potency of the tablets cannot be guaranteed after three months. The product contains Phenylketonurios and should be used following the enclosed pack insert for dosage information.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
